<SEC-DOCUMENT>0001654954-20-014090.txt : 20201231
<SEC-HEADER>0001654954-20-014090.hdr.sgml : 20201231
<ACCEPTANCE-DATETIME>20201231170651
ACCESSION NUMBER:		0001654954-20-014090
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20201228
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201231
DATE AS OF CHANGE:		20201231

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GT Biopharma, Inc.
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08092
		FILM NUMBER:		201429383

	BUSINESS ADDRESS:	
		STREET 1:		9350 WILSHIRE BLVD.
		STREET 2:		SUITE 203
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212
		BUSINESS PHONE:		(800) 304-9888

	MAIL ADDRESS:	
		STREET 1:		9350 WILSHIRE BLVD.
		STREET 2:		SUITE 203
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19940916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gtbp_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2020 Issuer Direct Corporation -->
<title>gtbp_8k</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 4px solid #000000; border-bottom: 1px solid #000000">
<!--style header--><br></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
UNITED STATES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SECURITIES AND EXCHANGE COMMISSION</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Washington, D.C. 20549</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
FORM 8-K</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
CURRENT REPORT</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Pursuant to Section 13 or 15(d) of the</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Securities Exchange Act of 1934</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Date of
Report (Date of earliest event reported): December 28,
2020</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
GT Biopharma, Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Exact
name of registrant as specified in its charter)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 31%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="text-decoration: underline">Delaware</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(State
or other jurisdiction of incorporation or
organization)</font></div>
</td>
<td style="vertical-align: top; width: 31%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="text-decoration: underline">000-08092</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Commission
File Number)</font></div>
</td>
<td style="vertical-align: top; width: 31%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="text-decoration: underline">94-1620407</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(IRS
Employer Identification No.)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
9350 Wilshire Blvd. Suite 203</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Beverly Hills, CA 90212</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Phone: (800) 304-9888</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Address,
including zip code, and telephone number, including area code,
of</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">registrant&#x2019;s
principal executive offices)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
N/A</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Former
name, former address and former fiscal year, if changed since last
report)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font>
&#x2610;</font> Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font>
&#x2610;</font> Soliciting material pursuant to Rule l 4a- l 2 under
the Exchange Act ( 17 CFR 240. l 4a- l 2)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font>
&#x2610;</font> Pre-commencement communications pursuant to Rule l
4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font>
&#x2610;</font> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240. l
3e-4(c))</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Securities
registered pursuant to Section 12(b) of the Act:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: bottom; width: 31%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Title of each class</font></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 31%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Trading Symbol</font></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 31%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Name of exchangeon which registered</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 31%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">N/A</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 31%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">N/A</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 31%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">N/A</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (&#xA7;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (&#xA7;240.12b-2 of this chapter).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Emerging
growth company &#x2610;<a name="Check1">
<!--anchor--></a></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. &#x2610;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 1px solid #000000; border-bottom: 4px solid #000000">
<!--style footer--><br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">Item 4.01.</font> Change in
Registrant&#x2019;s Certifying Accountant</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Resignation of Independent Registered Accounting Firm.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On December 28, 2020, GT Biopharma, Inc., a Delaware corporation
(the &#x201C;</font><font style="text-decoration: underline; color: #000000">Company</font><font style="color: #000000">&#x201D;),
was informed that its independent registered public accounting
firm, Seligson &amp; Giannattasio, LLP (&#x201C;</font><font style="text-decoration: underline; color: #000000">S&amp;G</font><font style="color: #000000">&#x201D;),
had resigned as of December 28, 2020.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The audit reports of S&amp;G on our financial statements for the
years ended December&#xA0;31, 2018 and December&#xA0;31, 2019 did
not contain an adverse opinion or a disclaimer of opinion, and were
not qualified or modified as to uncertainty, audit scope or
accounting principles, other than the statements related to our
Company&#x2019;s ability to continue as a going concern. During the
fiscal years ended December&#xA0;31, 2018 and December&#xA0;31,
2019, and through the subsequent interim period preceding
S&amp;G&#x2019;s resignation, there were no disagreements between
the Company and S&amp;G on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or
procedures, which disagreements, if not resolved to the
satisfaction of S&amp;G would have caused them to make reference
thereto in their reports on our financial statements for such
years. During the fiscal years ended December&#xA0;31, 2018 and
December&#xA0;31, 2019, and through the subsequent interim period
preceding S&amp;G&#x2019;s resignation, there were no reportable
events within the meaning set forth in Item 304(a)(1)(v) of
Regulation S-K.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 30, 2020, the Company provided S&amp;G with its
disclosures in this Current Report on Form 8-K disclosing the
resignation of S&amp;G and requested in writing that S&amp;G
furnish the Company with a letter addressed to the Securities and
Exchange Commission stating whether they agree with such
disclosure. A copy of S&amp;G&#x2019;s response is filed as Exhibit
16.1 to this Current Report on Form 8-K.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Engagement of Independent Accounting Firm.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
In connection with the resignation of S&amp;G, the Board of
Directors of the Company approved the engagement of Weinberg &amp;
Company, P.A. (&#x201C;</font><font style="text-decoration: underline; color: #000000">Weinberg</font><font style="color: #000000">&#x201D;)
to serve as the Company&#x2019;s independent registered public
accounting firm for the fiscal year ending December 31, 2020.
During the Company&#x2019;s two most recent fiscal years ended
December&#xA0;31, 2018 and December&#xA0;31, 2019, and through the
subsequent interim period preceding Weinberg&#x2019;s engagement,
the Company did not consult with Weinberg on either (a)&#xA0;the
application of accounting principles to a specified transaction,
either completed or proposed; or the type of audit opinion that may
be rendered on our financial statements, and Weinberg did not
provide either a written report or oral advice to us that Weinberg
concluded was an important factor considered by us in reaching a
decision as to the accounting, auditing or financial reporting
issue; or (b)&#xA0;any matter that was either the subject of a
disagreement, as defined in Item 304(a)(1)(iv) of Regulation S-K,
or a reportable event, as defined in Item 304(a)(1)(v) of
Regulation S-K.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">Item 9.01.</font> Financial Statements
and Exhibits.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">(d)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Exhibits</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 48px">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><a href="gtbp_ex16-1.htm"><font style="font-family: Times New Roman; font-size: 13px"><font style="background-color: #FFFFFF">16.1</font></font></a></div>
<div style="text-align: left; display: table-cell"><font style="background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Letter from Seligson &amp; Giannattasio, LLP</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SIGNATURE PAGE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pursuant
to the requirement of the Securities and Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align: top; width: 42%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
GT Biopharma, Inc.</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dated:
December 31, 2020</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:</font></div>
</td>
<td style="vertical-align: top; width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;/s/
Michael Handelman</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">Michael
Handelman</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Financial Officer</font></div>
</td>
<td style="vertical-align: middle; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">&#xA0;
<font style="font-family: Times New Roman; font-size: 13px">'''</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>2
<FILENAME>gtbp_ex16-1.htm
<DESCRIPTION>LETTER FROM SELIGSON & GIANNATTASIO, LLP
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2020 Issuer Direct Corporation -->
<title>gtbp_ex16-1</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Exhibit 16.1</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 51%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="gtbp_ex16-1000.jpg"></div>
</td>
<td style="vertical-align: top; width: 49%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="gtbp_ex16-1001.jpg"></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
December 31, 2020</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Securities and Exchange Commission</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
100 F Street N.E.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Washington, D.C. 20549</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have been furnished with a copy of the response to Item 4.01 of
Form 8-K for the event that occurred on December 28, 2020, to be
filed by our former client, GT Biopharma, Inc. We agree with the
statements made in response to that Item insofar as they relate to
our Firm.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Very truly yours,</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
/s/ Seligson &amp; Giannattasio, LLP</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gtbp_ex16-1000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex16-1000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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MW*T852.>A7OU/2CQCXE_L6[T:P^W1Z>NISM&][(%(A55R<;OEW$X +9 ST-
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M?_'Z .S\?7OB#2O#\FH:!-#]HB=%^SRPAQ)N8* #D8.2*C\$>-8O&>C2!O\
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MIH?B7[+IB+X?9$/V.60NT1PI4[E&1_B:]@L+V#4M/MKVV</#<1K+&P[J1D4
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MU;W.JPSS26W,.VYDC$9ZY 5ASP.:C_X163_H9=>_\"4_^(H_X127_H9=?_\
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J444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>gtbp_ex16-1001.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex16-1001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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M<U%#X:TFWE@DBM KP+LC8,<A?[OT]J &Z%K9UJVDN/L<EO&)&C0R,I+[6(/
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M\RJ"EN7X7=SG\@<<4 ;](:R;?75GUZ;26LKF&1(O.65U&QUSCC!SU]:UNW-
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4R_O"?.R05XZ8&#^=;G:@49H _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
